Cytosolic localization and in vitro assembly of human de novo thymidylate synthesis complex. (12th November 2021)
- Record Type:
- Journal Article
- Title:
- Cytosolic localization and in vitro assembly of human de novo thymidylate synthesis complex. (12th November 2021)
- Main Title:
- Cytosolic localization and in vitro assembly of human de novo thymidylate synthesis complex
- Authors:
- Spizzichino, Sharon
Boi, Dalila
Boumis, Giovanna
Lucchi, Roberta
Liberati, Francesca Romana
Capelli, Davide
Montanari, Roberta
Pochetti, Giorgio
Piacentini, Roberta
Parisi, Giacomo
Paone, Alessio
Rinaldo, Serena
Contestabile, Roberto
Tramonti, Angela
Paiardini, Alessandro
Giardina, Giorgio
Cutruzzolà, Francesca - Abstract:
- Abstract : De novo thymidylate synthesis is a crucial pathway for normal and cancer cells. Deoxythymidine monophosphate (dTMP) is synthesized by the combined action of three enzymes: serine hydroxymethyltransferase (SHMT1), dihydrofolate reductase (DHFR) and thymidylate synthase (TYMS), with the latter two being targets of widely used chemotherapeutics such as antifolates and 5‐fluorouracil. These proteins translocate to the nucleus after SUMOylation and are suggested to assemble in this compartment into the thymidylate synthesis complex. We report the intracellular dynamics of the complex in cancer cells by an in situ proximity ligation assay, showing that it is also detected in the cytoplasm. This result indicates that the role of the thymidylate synthesis complex assembly may go beyond dTMP synthesis. We have successfully assembled the dTMP synthesis complex in vitro, employing tetrameric SHMT1 and a bifunctional chimeric enzyme comprising human thymidylate synthase and dihydrofolate reductase. We show that the SHMT1 tetrameric state is required for efficient complex assembly, indicating that this aggregation state is evolutionarily selected in eukaryotes to optimize protein–protein interactions. Lastly, our results regarding the activity of the complete thymidylate cycle in vitro may provide a useful tool with respect to developing drugs targeting the entire complex instead of the individual components. Abstract : De novo thymidylate synthesis is a crucial pathway forAbstract : De novo thymidylate synthesis is a crucial pathway for normal and cancer cells. Deoxythymidine monophosphate (dTMP) is synthesized by the combined action of three enzymes: serine hydroxymethyltransferase (SHMT1), dihydrofolate reductase (DHFR) and thymidylate synthase (TYMS), with the latter two being targets of widely used chemotherapeutics such as antifolates and 5‐fluorouracil. These proteins translocate to the nucleus after SUMOylation and are suggested to assemble in this compartment into the thymidylate synthesis complex. We report the intracellular dynamics of the complex in cancer cells by an in situ proximity ligation assay, showing that it is also detected in the cytoplasm. This result indicates that the role of the thymidylate synthesis complex assembly may go beyond dTMP synthesis. We have successfully assembled the dTMP synthesis complex in vitro, employing tetrameric SHMT1 and a bifunctional chimeric enzyme comprising human thymidylate synthase and dihydrofolate reductase. We show that the SHMT1 tetrameric state is required for efficient complex assembly, indicating that this aggregation state is evolutionarily selected in eukaryotes to optimize protein–protein interactions. Lastly, our results regarding the activity of the complete thymidylate cycle in vitro may provide a useful tool with respect to developing drugs targeting the entire complex instead of the individual components. Abstract : De novo thymidylate synthesis is a crucial pathway for cancer cells that rely on deoxythymidine monophosphate (dTMP) to fuel DNA synthesis. dTMP is synthesized by three enzymes forming a transient protein–protein complex. We report the intracellular dynamics and localization of the dTMP synthesis complex in cancer cells, as well as its successful assembly in vitro . Our results provide a useful tool to develop drugs targeting the entire complex instead of the individual components. … (more)
- Is Part Of:
- FEBS journal. Volume 289:Number 6(2022)
- Journal:
- FEBS journal
- Issue:
- Volume 289:Number 6(2022)
- Issue Display:
- Volume 289, Issue 6 (2022)
- Year:
- 2022
- Volume:
- 289
- Issue:
- 6
- Issue Sort Value:
- 2022-0289-0006-0000
- Page Start:
- 1625
- Page End:
- 1649
- Publication Date:
- 2021-11-12
- Subjects:
- cancer metabolism -- protein–protein complex -- purine synthesis -- thymidylate synthesis -- transient interactions
Biochemistry -- Periodicals
Molecular biology -- Periodicals
Pathology, Molecular -- Periodicals
572 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01038983-000000000-00000 ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=ejb ↗
http://onlinelibrary.wiley.com/ ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=ejb ↗ - DOI:
- 10.1111/febs.16248 ↗
- Languages:
- English
- ISSNs:
- 1742-464X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3901.578500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21043.xml